NYSE:AXR AMREP (AXR) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free AXR Stock Alerts $20.77 +0.37 (+1.81%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$20.29▼$20.8950-Day Range$20.40▼$24.3652-Week Range$13.46▼$24.36Volume3,788 shsAverage Volume8,320 shsMarket Capitalization$109.46 millionP/E Ratio38.46Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get AMREP alerts: Email Address AMREP MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.93% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.45Based on 7 Articles This WeekInsider TradingAcquiring Shares$1.42 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.95 out of 5 starsFinance Sector491st out of 853 stocksSubdividers & Developers, Not Elsewhere Classified Industry1st out of 2 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for AMREP. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.93% of the float of AMREP has been sold short.Short Interest Ratio / Days to CoverAMREP has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AMREP has recently decreased by 3.14%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAMREP does not currently pay a dividend.Dividend GrowthAMREP does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AXR. Previous Next 2.5 News and Social Media Coverage News SentimentAMREP has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.News Coverage This WeekMarketBeat has tracked 7 news articles for AMREP this week, compared to 1 article on an average week.Search Interest2 people have searched for AXR on MarketBeat in the last 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AMREP insiders have bought 1,774.03% more of their company's stock than they have sold. Specifically, they have bought $1,421,451.00 in company stock and sold $75,850.00 in company stock.Percentage Held by Insiders37.00% of the stock of AMREP is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions59.85% of the stock of AMREP is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of AMREP is 38.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.76.Price to Earnings Ratio vs. SectorThe P/E ratio of AMREP is 38.46, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 49.61.Price to Book Value per Share RatioAMREP has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About AMREP Stock (NYSE:AXR)AMREP Corporation, through its subsidiaries, primarily engages in the real estate business. The company operates through two segments, Land Development and Homebuilding. It sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. In addition, the company owns mineral interests covering an area of approximately 55,000 surface acres of land in Sandoval County, New Mexico; and owns oil, gas, and minerals and mineral interests covering an area of approximately 147 surface acres of land in Brighton, Colorado. Further, the company focuses on selling single-family detached homes and attached homes. As of April 30, 2023, it owned approximately 17,000 acres in Sandoval County, New Mexico. The company owns an approximately 160-acre property in Brighton, Colorado. AMREP Corporation was founded in 1961 and is headquartered in Havertown, Pennsylvania.Read More AXR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AXR Stock News HeadlinesApril 26, 2024 | insidertrades.comInsider Selling: AMREP Co. (NYSE:AXR) VP Sells 1,833 Shares of StockApril 19, 2024 | insidertrades.comAMREP Co. (NYSE:AXR) Major Shareholder James H. Dahl Acquires 2,400 SharesApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 13, 2024 | insidertrades.comJames H. Dahl Acquires 1,800 Shares of AMREP Co. (NYSE:AXR) StockApril 5, 2024 | insidertrades.comJames H. Dahl Buys 3,000 Shares of AMREP Co. (NYSE:AXR) StockApril 2, 2024 | insidertrades.comInsider Buying: AMREP Co. (NYSE:AXR) Major Shareholder Buys 5,000 Shares of StockApril 27, 2024 | americanbankingnews.comAMREP Co. (NYSE:AXR) VP Adrienne Uleau Sells 1,833 SharesApril 27, 2024 | americanbankingnews.comAMREP Co. (NYSE:AXR) VP Sells $37,136.58 in StockApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | seekingalpha.comAMREP Is Getting More Aggressive With Building, But Still Not An OpportunityApril 20, 2024 | americanbankingnews.comJames H. Dahl Purchases 2,400 Shares of AMREP Co. (NYSE:AXR) StockApril 7, 2024 | cnn.comAMREP CorporationApril 6, 2024 | investing.comAmrep Corp insider purchases shares worth $66,600March 27, 2024 | investing.comAmrep Corp insider buys shares worth over $129kMarch 16, 2024 | investing.comAmrep Corp insider purchases shares worth over $46kMarch 12, 2024 | msn.comAMREP Corporation Reports Drop in Net Income Despite Revenue GrowthnMarch 11, 2024 | finanznachrichten.deAMREP Corporation: AMREP Reports Third Quarter Fiscal 2024 ResultsMarch 8, 2024 | globenewswire.comAMREP Reports Third Quarter Fiscal 2024 ResultsFebruary 1, 2024 | msn.com$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are BuyingJanuary 25, 2024 | seekingalpha.comAMREP Performs As Expected But Is No Longer An OpportunityJanuary 15, 2024 | finance.yahoo.comAMREP Corporation (NYSE:AXR) has caught the attention of institutional investors who hold a sizeable 43% stakeDecember 25, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of AMREP Corporation (NYSE:AXR)December 11, 2023 | msn.comAMREP GAAP EPS of $0.21, revenue of $8.85MDecember 11, 2023 | finance.yahoo.comAMREP Reports Second Quarter Fiscal 2024 ResultsDecember 11, 2023 | markets.businessinsider.comTop 5 Real Estate Stocks That May Implode This MonthDecember 11, 2023 | finance.yahoo.comAsk Robotti & Co.'s Bob Robotti, Theo van der Meer a QuestionNovember 26, 2023 | morningstar.comAmrep Corp AXRSee More Headlines Receive AXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMREP and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/08/2024Today4/27/2024Fiscal Year End4/30/2024Next Earnings (Estimated)7/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Subdividers & developers, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:AXR CUSIPN/A CIK6207 Webwww.amrepcorp.com Phone(610) 487-0905Fax609-716-8255Employees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.54 Trailing P/E Ratio38.46 Forward P/E RatioN/A P/E GrowthN/ANet Income$21.79 million Net Margins6.43% Pretax Margin5.99% Return on Equity2.54% Return on Assets2.44% Debt Debt-to-Equity RatioN/A Current Ratio4.63 Quick Ratio4.63 Sales & Book Value Annual Sales$48.68 million Price / Sales2.25 Cash Flow$4.17 per share Price / Cash Flow4.98 Book Value$21.12 per share Price / Book0.98Miscellaneous Outstanding Shares5,270,000Free Float3,321,000Market Cap$109.46 million OptionableNot Optionable Beta0.99 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Christopher V. Vitale (Age 48)President, CEO, Secretary & Director Comp: $511.04kMs. Adrienne M. Uleau (Age 56)Vice President of Finance & Accounting Comp: $229.22kKey CompetitorsStratus PropertiesNASDAQ:STRSOhio Valley BancNASDAQ:OVBCNuveen Select Maturities Municipal FundNYSE:NIMCitizens Community BancorpNASDAQ:CZWICB Financial ServicesNASDAQ:CBFVView All CompetitorsInsiders & InstitutionsAdrienne UleauSold 1,833 sharesTotal: $37,136.58 ($20.26/share)Adrienne UleauSold 1,833 sharesTotal: $38,712.96 ($21.12/share)James H DahlBought 2,400 shares on 4/18/2024Total: $52,368.00 ($21.82/share)James H DahlBought 142 shares on 4/16/2024Total: $2,979.16 ($20.98/share)James H DahlBought 1,800 shares on 4/11/2024Total: $39,582.00 ($21.99/share)View All Insider TransactionsView All Institutional Transactions AXR Stock Analysis - Frequently Asked Questions How have AXR shares performed in 2024? AMREP's stock was trading at $21.97 at the beginning of 2024. Since then, AXR stock has decreased by 5.5% and is now trading at $20.77. View the best growth stocks for 2024 here. Are investors shorting AMREP? AMREP saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 24,300 shares, an increase of 17.4% from the February 29th total of 20,700 shares. Based on an average daily volume of 6,800 shares, the short-interest ratio is currently 3.6 days. Currently, 0.9% of the company's stock are short sold. View AMREP's Short Interest. When is AMREP's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024. View our AXR earnings forecast. How were AMREP's earnings last quarter? AMREP Co. (NYSE:AXR) released its quarterly earnings data on Friday, March, 8th. The business services provider reported $0.02 earnings per share (EPS) for the quarter. The business services provider earned $12.69 million during the quarter. AMREP had a trailing twelve-month return on equity of 2.54% and a net margin of 6.43%. What is Theodore J. Gaasche's approval rating as AMREP's CEO? 2 employees have rated AMREP Chief Executive Officer Theodore J. Gaasche on Glassdoor.com. Theodore J. Gaasche has an approval rating of 100% among the company's employees. This puts Theodore J. Gaasche in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of AMREP own? Based on aggregate information from My MarketBeat watchlists, some companies that other AMREP investors own include Carnival Co. & (CCL), Blackrock Resources & Commodities Strategy Trust (BCX), BlackRock Enhanced International Dividend Trust (BGY), Bank of Nova Scotia (BNS), General Mills (GIS), Kohl's (KSS), Permian Basin Royalty Trust (PBT), Putnam Premier Income Trust (PPT), AbbVie (ABBV) and Algonquin Power & Utilities (AQN). How do I buy shares of AMREP? Shares of AXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AXR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMREP Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
